Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
;
: 643-655, 2017.
Article
in English
| WPRIM
| ID: wpr-167303
ABSTRACT
PURPOSE:
KX-01 is a novel dual inhibitor of Src and tubulin. Unlike previous Src inhibitors that failed to show clinical benefit during treatment of breast cancer, KX-01 can potentially overcome the therapeutic limitations of current Src inhibitors through inhibition of both Src and tubulin. The present study further evaluates the activity and mechanism of KX-01 in vitro and in vivo. MATERIALS ANDMETHODS:
The antitumor effect of KX-01 in triple negative breast cancer (TNBC) cell lines was determined by MTT assay. Wound healing and immunofluorescence assays were performed to evaluate the action mechanisms of KX-01. Changes in the cell cycle and molecular changes induced by KX-01 were also evaluated. A MDA-MB-231 mouse xenograft model was used to demonstrate the in vivo effects.RESULTS:
KX-01 effectively inhibited the growth of breast cancer cell lines. The expression of phospho-Src and proliferative-signaling molecules were down-regulated in KX-01-sensitive TNBC cell lines. In addition, migration inhibition was observed by wound healing assay. KX-01-induced G2/M cell cycle arrest and increased the aneuploid cell population in KX-01-sensitive cell lines. Multi-nucleated cells were significantly increased after KX-01 treatment. Furthermore, KX-01 effectively delayed tumor growth in a MDA-MB-231 mouse xenograft model.CONCLUSION:
KX-01 effectively inhibited cell growth and migration of TNBC cells. Moreover, this study demonstrated that KX-01 showed antitumor effects through the inhibition of Src signaling and the induction of mitotic catastrophe. The antitumor effects of KX-01 were also demonstrated in vivo using a mouse xenograft model.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Tubulin
/
Wound Healing
/
In Vitro Techniques
/
Breast Neoplasms
/
Cell Cycle
/
Cell Line
/
Fluorescent Antibody Technique
/
Src-Family Kinases
/
Cell Cycle Checkpoints
/
Heterografts
Limits:
Animals
Language:
English
Journal:
Cancer Research and Treatment
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS